应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09995 荣昌生物
未开盘 07-02 16:08:21
80.050
+5.750
+7.74%
最高
81.350
最低
77.100
成交量
917.12万
今开
78.950
昨收
74.300
日振幅
5.72%
总市值
451.17亿
流通市值
166.97亿
总股本
5.64亿
成交额
7.30亿
换手率
4.40%
流通股本
2.09亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
荣昌生物(688331)披露使用闲置募集资金及自有资金购买结构性存款公告,7月2日股价上涨1.04%
证券之星 · 07-02 22:10
荣昌生物(688331)披露使用闲置募集资金及自有资金购买结构性存款公告,7月2日股价上涨1.04%
荣昌生物:拟向浦发银行烟台分行购买理财产品合计2.8亿元
南方财经网 · 07-02 20:33
荣昌生物:拟向浦发银行烟台分行购买理财产品合计2.8亿元
荣昌生物追加理财配置:2.8亿元闲置资金认购浦发银行结构性存款
公告速递 · 07-02 20:18
荣昌生物追加理财配置:2.8亿元闲置资金认购浦发银行结构性存款
荣昌生物(09995.HK)认购合共2.8亿元理财产品
智通财经 · 07-02 20:17
荣昌生物(09995.HK)认购合共2.8亿元理财产品
异动解读|荣昌生物盘中上涨7.34%,医保国谈初审名单公布叠加解禁减持受限提振板块情绪
行情直击 · 07-02 10:01
异动解读|荣昌生物盘中上涨7.34%,医保国谈初审名单公布叠加解禁减持受限提振板块情绪
荣昌生物(688331)1.93亿股限售股将于7月1日解禁,占总股本34.16%
证券之星 · 07-01 08:03
荣昌生物(688331)1.93亿股限售股将于7月1日解禁,占总股本34.16%
389.75亿元市值限售股今日解禁
格隆汇 · 07-01 07:48
389.75亿元市值限售股今日解禁
异动解读|荣昌生物盘中下跌5.27%,巨额限售股解禁在即引发获利回吐
行情直击 · 06-30 10:34
异动解读|荣昌生物盘中下跌5.27%,巨额限售股解禁在即引发获利回吐
港股异动 | 荣昌生物(09995.HK)盘中涨超18% 维迪西妥单抗“三药联合”方案刷新患者生存纪录
智通财经 · 06-29
港股异动 | 荣昌生物(09995.HK)盘中涨超18% 维迪西妥单抗“三药联合”方案刷新患者生存纪录
港股午评:恒指涨2.12%重回23000点 科指涨3.68% 科网股普涨 创新药概念股爆发 美团、百度涨超7%
新浪港股 · 06-29
港股午评:恒指涨2.12%重回23000点 科指涨3.68% 科网股普涨 创新药概念股爆发 美团、百度涨超7%
港股生物医药板块反弹,荣昌生物涨超16%,创新药主线全面爆发
老虎资讯综合 · 06-29
港股生物医药板块反弹,荣昌生物涨超16%,创新药主线全面爆发
创新药概念全线扬升 晶泰控股(02228)涨逾14% 机构指创新药仍为行业核心增量
金吾财讯 · 06-29
创新药概念全线扬升 晶泰控股(02228)涨逾14% 机构指创新药仍为行业核心增量
异动解读|荣昌生物盘中上涨5.38%,解禁股东受限减持叠加新药获批催化
行情直击 · 06-29
异动解读|荣昌生物盘中上涨5.38%,解禁股东受限减持叠加新药获批催化
每周股票复盘:荣昌生物(688331)限售股解禁34.16%将上市
证券之星 · 06-28
每周股票复盘:荣昌生物(688331)限售股解禁34.16%将上市
【券商聚焦】中信证券:中国创新药BD交易金额超预期增长 即将进入密集数据催化期
金吾财讯 · 06-25
【券商聚焦】中信证券:中国创新药BD交易金额超预期增长 即将进入密集数据催化期
异动解读|荣昌生物盘中上涨5.31%,港股创新药板块延续反弹叠加解禁减持受限缓解抛压担忧
行情直击 · 06-24
异动解读|荣昌生物盘中上涨5.31%,港股创新药板块延续反弹叠加解禁减持受限缓解抛压担忧
医药板块逆市走高 山东新华制药(00719)涨23.59%、康诺亚-B(02162)涨5.38%
金吾财讯 · 06-23
医药板块逆市走高 山东新华制药(00719)涨23.59%、康诺亚-B(02162)涨5.38%
异动解读|荣昌生物盘中上涨5.02%,港股创新药板块集体反弹叠加解禁减持受限缓解抛压担忧
行情直击 · 06-23
异动解读|荣昌生物盘中上涨5.02%,港股创新药板块集体反弹叠加解禁减持受限缓解抛压担忧
港股直击 | 生物医药股及医药外包股造好,康宁杰瑞制药、康诺亚升7%,荣昌生物、昭衍新药升5%
老虎资讯综合 · 06-23
港股直击 | 生物医药股及医药外包股造好,康宁杰瑞制药、康诺亚升7%,荣昌生物、昭衍新药升5%
荣昌生物(688331)披露首次公开发行限售股份上市流通公告,6月22日股价下跌0.42%
证券之星 · 06-22
荣昌生物(688331)披露首次公开发行限售股份上市流通公告,6月22日股价下跌0.42%
加载更多
公司概况
公司名称:
荣昌生物
所属市场:
SEHK
上市日期:
--
主营业务:
荣昌生物制药(烟台)股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":80.05,"timestamp":1782979701011,"preClose":74.3,"halted":0,"volume":9171245,"delay":0,"changeRate":0.07738896366083446,"floatShares":208581239,"shares":563608243,"eps":1.4904024940198424,"marketStatus":"未开盘","change":5.75,"latestTime":"07-02 16:08:21","open":78.95,"high":81.35,"low":77.1,"amount":729888129,"amplitude":0.057201,"askPrice":80.1,"askSize":3500,"bidPrice":80.05,"bidSize":45500,"shortable":3,"etf":0,"ttmEps":2.697048528089095,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":0,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":74.3,"openAndCloseTimeList":[[1782955800000,1782964800000],[1782968400000,1782979200000]],"volumeRatio":1.2264930452435379,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":140.45,"timestamp":1782975600000,"preClose":139,"halted":0,"volume":16840000,"delay":0,"premium":"-50.67"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"2648685337","title":"荣昌生物(688331)披露使用闲置募集资金及自有资金购买结构性存款公告,7月2日股价上涨1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648685337?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:10","pubTimestamp":1783001424,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘,荣昌生物报收于140.45元,较前一交易日上涨1.04%,最新总市值为792.81亿元。该股当日开盘138.0元,最高145.86元,最低134.7元,成交额达23.58亿元,换手率为4.73%。近日,荣昌生物制药(烟台)股份有限公司与浦发银行烟台分行订立浦发银行理财产品9号协议及10号协议,分别使用人民币80.0百万元闲置募集资金和人民币200.0百万元闲置自有资金购买保本浮动收益类结构性存款产品。董事会认为该等交易条款公平合理,符合公司及股东整体利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200041859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2328871848.SGD","LU1064130708.USD","LU2488822045.USD","688331","LU1969619763.USD","BK1583","BK1574","BK1161","09995","LU2148510915.USD","BK0239","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648500532","title":"荣昌生物:拟向浦发银行烟台分行购买理财产品合计2.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648500532","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648500532?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:33","pubTimestamp":1782995631,"startTime":"0","endTime":"0","summary":"荣昌生物:拟向浦发银行烟台分行购买理财产品合计2.8亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607023792123096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064131003.USD","BK0012","LU0469268626.HKD","LU1064130708.USD","LU1808992512.USD","600000","BK1161","BK0015","688331","LU1979443071.USD","SGXZ49509284.SGD","BK0201","BK1583","BK0028","BK0086","BK1574","09995","BK0187","LU2148510915.USD","LU1934453819.USD","BK0188","BK0278","SGXZ81163826.USD","LU1969619763.USD","BK0239","LU2488822045.USD","LU2328871848.SGD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147160844","title":"荣昌生物追加理财配置:2.8亿元闲置资金认购浦发银行结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=1147160844","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147160844?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:18","pubTimestamp":1782994728,"startTime":"0","endTime":"0","summary":"7月2日,荣昌生物宣布与浦发银行烟台分行签署两份新理财协议,再度动用合计280百万元闲置资金购买结构性存款产品。加上本次2.8亿元,半年内与浦发银行烟台分行的理财总额达9.8亿元。\\n\\n荣昌生物表示,购买保本浮动收益型结构性存款旨在提高闲置资金的使用效率,在风险可控前提下获取高于同期银行定期存款的收益,符合公司及股东整体利益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648598507","title":"荣昌生物(09995.HK)认购合共2.8亿元理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2648598507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648598507?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:17","pubTimestamp":1782994659,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","09995","BK1583","LU1969619763.USD","BK1574","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194658223","title":"异动解读|荣昌生物盘中上涨7.34%,医保国谈初审名单公布叠加解禁减持受限提振板块情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1194658223","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194658223?lang=zh_cn&edition=full","pubTime":"2026-07-02 10:01","pubTimestamp":1782957699,"startTime":"0","endTime":"0","summary":"7月2日,荣昌生物盘中上涨7.34%,报77.85港元,成交额2.37亿港元。公司层面,7月1日1.93亿股限售股正式解禁,占总股本34.16%,但因公司现金分红未达监管规定,解禁股东不得通过集中竞价或大宗交易方式减持A股股份,实质性抛压远低于预期。A股方面,荣昌生物7月1日收涨6.71%,主力资金净流入2.07亿元,市场情绪快速修复。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648182593","title":"荣昌生物(688331)1.93亿股限售股将于7月1日解禁,占总股本34.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648182593","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648182593?lang=zh_cn&edition=full","pubTime":"2026-07-01 08:03","pubTimestamp":1782864206,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,荣昌生物于7月1日将有1.93亿股限售股份解禁,为公司追加承诺限售股份上市流通,占公司总股本34.16%。本次解禁后,公司已无限售股份。本文数据来源于荣昌生物公告,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100009454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","BK0239","LU2488822045.USD","LU2328871848.SGD","BK1574","LU1969619763.USD","688331","LU1064130708.USD","09995","BK1161","LU1064131003.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593868","title":"389.75亿元市值限售股今日解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593868","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648593868?lang=zh_cn&edition=full","pubTime":"2026-07-01 07:48","pubTimestamp":1782863294,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2328871848.SGD","BK1161","09995","BK1574","LU1969619763.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198984720","title":"异动解读|荣昌生物盘中下跌5.27%,巨额限售股解禁在即引发获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1198984720","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198984720?lang=zh_cn&edition=full","pubTime":"2026-06-30 10:34","pubTimestamp":1782786853,"startTime":"0","endTime":"0","summary":"6月30日,荣昌生物盘中下跌5.27%,报75.5港元,成交额2.83亿港元。消息面上,公司1.93亿股首发限售股将于7月1日上市流通,占总股本34.16%,对应解禁市值约217.85亿元,为当周A股解禁规模第二大个股。尽管公司公告明确指出,因现金分红未达监管规定,本次解禁股东不得通过集中竞价或大宗交易方式减持A股股份,实质性减持压力低于预期,但巨额解禁叠加前日大涨后获利盘涌出,短期股价仍承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647215223","title":"港股异动 | 荣昌生物(09995.HK)盘中涨超18% 维迪西妥单抗“三药联合”方案刷新患者生存纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2647215223","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647215223?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:27","pubTimestamp":1782718038,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1969619763.USD","BK1161","BK1583","LU2328871848.SGD","09995","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647340276","title":"港股午评:恒指涨2.12%重回23000点 科指涨3.68% 科网股普涨 创新药概念股爆发 美团、百度涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647340276","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647340276?lang=zh_cn&edition=full","pubTime":"2026-06-29 12:00","pubTimestamp":1782705600,"startTime":"0","endTime":"0","summary":"截至午间收盘,恒生指数涨2.12%,报23153.43,恒生科技指数涨3.68%,国企指数涨2.81%。盘面上,科网股涨多跌少,联想跌超9%,哔哩哔哩涨超8%,美团、百度涨超7%,阿里巴巴涨超6%;创新药概念股爆发,荣昌生物涨超15%;机器人概念股走强,地平线机器人涨超15%;光通信板块走弱,长飞光纤光缆跌超8%;今日三只新股上市,礼邦医药-B涨超100%、海光芯正涨超45%、白鸽在线涨超317%。 创新药概念股爆发,荣昌生物涨超15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-06-29/doc-iniezxay2294894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0762542818.HKD","07200","HSTECH","BK1574","LU0871576103.HKD","LU0873338254.USD","LU1688375341.USD","LU0797268264.HKD","LU0072913022.USD","LU0043850808.USD","03690","LU0048580855.USD","LU1048596156.SGD","LU1242518931.SGD","LU1868838027.USD","LU0348814723.USD","LU0417516902.SGD","06869","LU0359201885.HKD","89888","LU1064131003.USD","09067","LU1770034418.SGD","LU0196878994.USD","LU0463099449.HKD","IE00B3M56506.USD","LU0531971595.HKD","LU0630378429.USD","SG9999002828.SGD","LU0708995583.HKD","BK1615","LU2488822045.USD","LU0140636845.USD","HMTD.SI","LU0865486749.SGD","LU0164872284.USD","03033","LU1323998911.USD","HSI","LU0054450605.USD","02833","BK1142","LU1152091168.USD","LU1251922891.USD","IE00B031HY20.USD","SG9999002562.SGD","BK1575","LU0210526637.USD","LU0106252389.USD","LU0029875118.USD","LU0307460666.USD","LU2476274720.SGD","LU1868837722.USD","BK1610","LU0762541174.USD","LU0577902371.SGD","SG9999006597.SGD","LU0918141887.USD","LU0543330483.HKD","BK1591","LU0211977185.USD","LU0588545730.USD","LU1969619763.USD","BK1604","LU0261950983.USD","LU0828237510.HKD","BK1587","LU0326948709.USD","LU0823426308.USD","LU0370786039.SGD","LU1105468828.SGD","IE00BF5LJ272.USD","LU1734074674.USD","MCHmain","LU0594300179.USD","LU0633140560.USD","IE0008368742.USD","LU1675838814.USD","LU1720050803.USD","LU2087589342.USD","SG9999001689.USD","LU0918141705.HKD","LU1719994722.HKD","LU0229945570.USD","LU0650527681.SGD","LU0979878070.USD","09088","07500","02800","HK0000320223.HKD","LU0449509016.USD","LU0588545904.SGD","LU0314109678.HKD","LU2152927971.USD","LU0315178854.USD","LU0345776255.USD","LU0231483743.USD","SG9999002463.SGD","09888","LU0197773160.USD","LU2778985437.USD","03419","LU0197773673.USD","LU0228659784.USD","LU1226287529.USD","LU0821914370.USD","LU2097828474.EUR","LU0117841782.USD","LU2257852520.SGD","03037","BK1583","LU0456846285.SGD","LU0589944569.HKD","09115","LU0700851271.USD","LU0541502299.USD","LU0052750758.USD","LU0143863784.USD","LU0823039010.USD","BK1161","LU1303224171.USD","LU0072462343.USD","LU0348788117.USD","LU0164880469.USD","LU0828237940.HKD","LU0287142896.SGD","LU1993786604.SGD","LU2125910500.SGD","LU1960683339.HKD","MPNGY","LU0327786744.USD","LU0067412154.USD","BK1589","LU0128522157.USD","LU0630378692.HKD","LU0823040885.USD","LU1242518857.USD","LU1868837565.USD","LU2242644610.SGD","LU0683595622.HKD","BK1609","LU0499858602.USD","LU0577902298.EUR","LU0251144936.SGD","BK1095","LU0737861699.HKD","LU0348827113.USD","SG9999000459.SGD","LU2039709279.SGD","LU0228367735.SGD","IE0034224299.USD","LU0540923850.HKD","IE00B0JY6N72.USD","LU0541501648.USD","LU0143863198.USD","LU0348805143.USD","LU1048588211.SGD","IE0032431581.USD","LU0173614495.USD","LU1102505929.USD","LU0640798160.USD","07300","BK1588","07226","LU0868486357.SGD","LU0588546209.SGD","02837","09995","IE00BPRC5H50.USD","LU0819123356.HKD","HK0000320264.USD","LU1328615791.USD","SG9999000327.SGD","LU0326950275.SGD","LU0588545490.SGD","LU0856984785.SGD","LU2097828714.EUR","LU0819121731.USD","HK0000306701.USD","IE00B29SXG58.USD","LU0417516738.SGD","03067","LU0823038988.USD","LU2476274308.USD","LU2045819591.USD","LU0348825331.USD","82800","LU0455707207.USD","LU0577902454.USD","LU1023057109.AUD","LU0611395673.USD","LU0502904849.HKD","LU1880383440.USD","LU2399975544.HKD","LU0501845795.SGD","LU0049853897.USD","LU0762540952.USD","LU0348735423.USD","LU0880133367.SGD","LU2148510915.USD","LU0823426480.USD","BK1233","LU0039217434.USD","LU0499858438.USD","BK1618","LU0047713382.USD","LU0561508036.HKD","HHImain","LU1481107354.HKD","LU0594300419.USD","LU0831093199.SGD","BK1149","LU0345775950.USD","LU0320764599.SGD","LU0634319403.HKD","LU1152091754.HKD","LU0011963245.USD","LU2097828557.USD","LU0509642566.USD","LU1807302812.USD","LU1115378108.SGD","688331","LU0543330566.HKD","LU0577902538.SGD","LU0577902611.USD","83115","LU0054237671.USD","03088","LU0269904917.USD","LU1008478684.HKD","LU2097828631.EUR","LU1831875114.USD","LU0572944931.SGD","LU0672654166.SGD","03115","LU1794554557.SGD","LU0165289439.USD","LU0605514214.HKD","BK1521","LU1224709979.USD","91171","LU0051755006.USD","LU0149721374.USD","LU2226246903.HKD","LU0214875030.USD","LU0244354667.USD","LU1961090484.USD","IE00B543WZ88.USD","LU0164865239.USD","LU0633140727.USD","LU1188198961.HKD","601869","LU1808992512.USD","LU2097828805.USD","LU0593848301.USD","03423","LU0456827905.SGD","LU1813983027.USD","LU0084288322.USD","LU0823041008.USD","BK1523","513600","LU0315179316.USD","LU0431992006.USD","LU0449515922.USD","LU1102505762.USD","LU0320764755.SGD","LU1282648689.USD","LU1770036033.HKD","SG9999014674.SGD","BK1506","LU0181495838.USD","LU1064130708.USD","03032","LU1880383366.USD","LU1328277881.USD","IE0008369823.USD","LU0359201612.USD","LU0878005551.USD","LU0163747925.USD","LU0348816934.USD","LU2328871848.SGD","SG9999001903.USD","BIDU","HK0000306685.HKD","LU0828238088.HKD","LU0048597586.USD","LU0132412106.USD","03417","07552","LU0359202008.SGD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159164688","title":"港股生物医药板块反弹,荣昌生物涨超16%,创新药主线全面爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=1159164688","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159164688?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:55","pubTimestamp":1782701710,"startTime":"0","endTime":"0","summary":"6月29日,港股生物医药股集体走强,荣昌生物涨超16%,康诺亚-B、诺诚健华、康方生物均涨超12%。板块上涨主要受创新药出海、BD交易活跃及临床管线进展预期带动,资金加速回流创新药和CXO方向。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","03347","02162","09969","02269","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647475483","title":"创新药概念全线扬升 晶泰控股(02228)涨逾14% 机构指创新药仍为行业核心增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2647475483","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647475483?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:33","pubTimestamp":1782700428,"startTime":"0","endTime":"0","summary":"消息面上,华鑫证券新近研究表示,自2015年创新药审批改革开始,创新药逐步成为医药行业的核心增量。以恒瑞医药为代表的创新药企业,创新药的收入比重持续提升。6月份以来,已有药明康德等企业开始公告回购或增持方案,逐步扭转市场对医药行业的信心。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984679","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","LU1328277881.USD","IE00B5MMRT66.SGD","LU0348735423.USD","09995","LU0348783233.USD","LU0540923850.HKD","LU2476274308.USD","LU0417516902.SGD","LU0348825331.USD","LU1720050803.USD","LU1226287529.USD","IE00BZ08YS42.EUR","LU0348827113.USD","LU1969619763.USD","LU1993786604.SGD","LU0140636845.USD","LU0634319403.HKD","06855","LU2476274720.SGD","09926","01093","159992","02157","LU1961090484.USD","LU1008478684.HKD","BK1583","LU1226287792.SGD","LU0067412154.USD","IE00B543WZ88.USD","LU0072913022.USD","LU0348767384.USD","02637","BK1141","LU1226288253.USD","LU0348784397.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","02162","BK1574","LU0417516571.SGD","LU1960683339.HKD","06978","09969","LU0326950275.SGD","LU0880133367.SGD","02228","LU0315179316.USD","LU0348766576.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140342189","title":"异动解读|荣昌生物盘中上涨5.38%,解禁股东受限减持叠加新药获批催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1140342189","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140342189?lang=zh_cn&edition=full","pubTime":"2026-06-29 09:45","pubTimestamp":1782697530,"startTime":"0","endTime":"0","summary":"6月29日,荣昌生物盘中上涨5.38%,报73.0港元,成交额7012.17万港元。消息面上,公司1.93亿股首发限售股将于7月1日上市流通,占总股本34.16%。但公告明确指出,因公司现金分红未达到相关监管规定,本次解除限售的股东不得通过集中竞价或大宗交易方式减持A股股份,实质性减持压力大幅低于市场预期。此外,公司核心产品泰它西普近期获批干燥综合征及IgA肾病两项新适应症,已累计五个适应症获批上市,商业化放量预期增强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315337","title":"每周股票复盘:荣昌生物(688331)限售股解禁34.16%将上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646315337?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:09","pubTimestamp":1782587350,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,荣昌生物报收于112.99元,较上周的114.48元下跌1.3%。本周,荣昌生物6月24日盘中最高价报121.55元。公司公告汇总荣昌生物首次公开发行A股54,426,301股,于2022年3月31日上市。截至2026年1月,公司总股本增至564,477,483股。本次限售股份上市流通数量为192,803,132股,占总股本34.16%,涉及8名股东,上市流通日期为2026年7月1日。保荐机构华泰联合证券对本次限售股解禁无异议。截至公告日,相关股东未出现违反承诺情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","BK0239","LU1969619763.USD","BK1161","BK1583","LU1064131003.USD","LU2148510915.USD","LU2328871848.SGD","LU2488822045.USD","09995","688331","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646840322","title":"【券商聚焦】中信证券:中国创新药BD交易金额超预期增长 即将进入密集数据催化期","url":"https://stock-news.laohu8.com/highlight/detail?id=2646840322","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646840322?lang=zh_cn&edition=full","pubTime":"2026-06-25 09:03","pubTimestamp":1782349398,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研报指,2026年以来,中国创新药BD交易金额超预期增长,产业全球竞争力进一步提升;国内市场快速放量,从2025年报来看,头部创新药企业在新产品驱动下,创新药收入快速增长,Biopharma陆续进入盈利拐点。研报认为创新药产业全球价值凸显,接下来将进入密集数据催化期。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984448","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","LU2328871848.SGD","LU2097828474.EUR","06978","06030","LU2289578879.USD","LU1813983027.USD","LU1064130708.USD","SG9999002463.SGD","LU0823426480.USD","IE00B031HY20.USD","LU0856984785.SGD","LU0327786744.USD","01093","01801","06160","IE00B5MMRT66.SGD","LU0405327148.USD","01877","BK0196","BK0028","LU0348767384.USD","LU1960683339.HKD","09688","BD","IE00BZ08YT58.USD","SG9999002562.SGD","IE00B0JY6N72.USD","LU0359202008.SGD","LU0501845795.SGD","LU0540923850.HKD","09926","09995","BK1574","LU1997245094.SGD","LU1328277881.USD","06185","LU2039709279.SGD","600030","LU1242518857.USD","159992","LU1226288253.USD","SG9999004220.SGD","02142","01177","02616","BK1610","02269","LU0181495838.USD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187281348","title":"异动解读|荣昌生物盘中上涨5.31%,港股创新药板块延续反弹叠加解禁减持受限缓解抛压担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1187281348","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187281348?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:54","pubTimestamp":1782266094,"startTime":"0","endTime":"0","summary":"6月24日,荣昌生物盘中上涨5.31%,报70.5港元/股,成交额1.21亿港元。消息面上,港股生物科技板块连续第二日集体反弹,科伦博泰生物涨8.49%、康方生物涨5.56%、三生制药涨5.17%、信达生物涨4.9%,行业情绪持续修复。此外,公司此前公告1.93亿股首发限售股将于7月1日上市流通,占总股本34.16%,但因公司未满足现金分红条件,解禁股东不得通过集中竞价或大宗交易方式减持A股股份,实际抛压预期大幅缓解,市场对解禁冲击的担忧进一步消退。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645001206","title":"医药板块逆市走高 山东新华制药(00719)涨23.59%、康诺亚-B(02162)涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645001206","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645001206?lang=zh_cn&edition=full","pubTime":"2026-06-23 10:08","pubTimestamp":1782180500,"startTime":"0","endTime":"0","summary":"市场交易结构出现变化,医药与科技板块不再呈现明显跷跷板效应,医疗服务、CXO赛道带动板块韧性修复。临近二季度末,市场开始提前交易行业业绩预期,资金重点布局两大主线,分别为商业化放量提速的创新药标的,以及受益于投融资回暖的CXO、生命科学上游龙头。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984274","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","09995","02269","159938","01877","LU1242518857.USD","09688","LU0140636845.USD","LU0039217434.USD","LU1880383366.USD","BK1576","LU0359201612.USD","09926","LU0456827905.SGD","BK1191","IE00B5MMRT66.SGD","LU0327786744.USD","LU0307460666.USD","LU0348783233.USD","LU0856984785.SGD","LU0052750758.USD","BK1583","LU2328871848.SGD","LU0051755006.USD","06160","LU2039709279.SGD","LU1251922891.USD","LU0516423091.SGD","LU0359202008.SGD","LU0516422366.SGD","IE00BPRC5H50.USD","BK1161","LU0516422952.EUR","LU0326950275.SGD","LU0979878070.USD","02268","LU1303224171.USD","06990","BK1589","LU3063872942.SGD","00719","09939","LU0320764599.SGD","LU0456846285.SGD","02162","SG9999002562.SGD","LU0588546209.SGD","09969","IE00B0JY6N72.USD","LU0417516902.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139285253","title":"异动解读|荣昌生物盘中上涨5.02%,港股创新药板块集体反弹叠加解禁减持受限缓解抛压担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1139285253","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139285253?lang=zh_cn&edition=full","pubTime":"2026-06-23 10:02","pubTimestamp":1782180164,"startTime":"0","endTime":"0","summary":"6月23日,荣昌生物盘中上涨5.02%,报68.9港元/股,成交额1.13亿港元。消息面上,港股生物医药板块在前一交易日大幅下挫后集体反弹,康宁杰瑞制药、康诺亚涨7%,康方生物涨4.28%,信达生物涨3.19%,行业情绪明显修复。此外,公司6月22日公告1.93亿股首发限售股将于7月1日上市流通,占总股本34.16%,但因公司未满足现金分红条件,解禁股东不得通过集中竞价或大宗交易方式减持A股股份,实际抛压预期大幅缓解,市场对解禁冲击的担忧有所消退。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131093292","title":"港股直击 | 生物医药股及医药外包股造好,康宁杰瑞制药、康诺亚升7%,荣昌生物、昭衍新药升5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131093292","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131093292?lang=zh_cn&edition=full","pubTime":"2026-06-23 09:49","pubTimestamp":1782179371,"startTime":"0","endTime":"0","summary":"生物医药股及医药外包股造好,康宁杰瑞制药、康诺亚升7%,荣昌生物、昭衍新药升5%,药明巨诺升3%。","market":"us","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","09966","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645073811","title":"荣昌生物(688331)披露首次公开发行限售股份上市流通公告,6月22日股价下跌0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645073811","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645073811?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:19","pubTimestamp":1782137959,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘,荣昌生物报收于114.0元,较前一交易日下跌0.42%,最新总市值为643.5亿元。近日,荣昌生物制药(烟台)股份有限公司发布《首次公开发行限售股份上市流通公告》。公告显示,公司首次公开发行限售股份将于2026年7月1日上市流通,本次解除限售股份数量为192,803,132股,占公司当前总股本的34.16%。上述股份原锁定期为公司上市之日起3个完整会计年度,因触发承诺条件延长6个月。截至公告日,相关股东未出现违反承诺情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200038872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","09995","BK1161","BK0239","LU1064130708.USD","BK1574","LU2488822045.USD","LU2148510915.USD","LU2328871848.SGD","688331","LU1969619763.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1428},{"period":"1month","weight":0.0437},{"period":"3month","weight":-0.3051},{"period":"6month","weight":0.0869},{"period":"1year","weight":0.4489},{"period":"ytd","weight":0.1118}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":-0.1146},{"period":"3month","weight":-0.0821},{"period":"6month","weight":-0.1247},{"period":"1year","weight":-0.0482},{"period":"ytd","weight":-0.1005}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药(烟台)股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.014034},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}